Abstract
To the Editor: Kaposi Sarcoma (KS) is a relatively rare cutaneous and mucous membrane cancer,1 disproportionately affecting HIV-infected patients in the United States.2 Since large KS multi-center studies are outdated, we aimed to update demographics and characterize trends in KS presentation and treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
